| Literature DB >> 31998771 |
Jiajia Wang1,2, Jitao Li1,2, Qianqian Ge1,2, Zhao Chen1,2, Jian Li1,2.
Abstract
The Exopalaemon carinicauda could be a useful crustacean laboratory animal in many research fields. We newly established an inbred line of Exopalaemon carinicauda named EC4 inbred line by brother×sister mating and keeping to F 11 generation. Trends in heterozygosity in the process of producing EC4 inbred line were examined through the characterization of polymorphisms based on gene frequencies of SNP and EST-SSR loci. The results demonstrated that the number of alleles (N), observed heterozygosity (Ho), expected heterozygosity (He), and polymorphism information content (PIC) gradually decreased with the increase of inbreeding generations. The genetic detection results indicated that 9 (29.03%, 9/31) of the SNP loci and 15 (32.61%, 15/46) of the EST-SSR loci were homozygous in F 11 generation of EC4 inbred line. The variation of the growth-related traits, the immune responses, and antioxidant status were described in experimental full-sibling inbred populations of E. carinicauda at five levels of inbreeding coefficient (F = 0.785, F = 0.816, F = 0.859, F = 0.886, F = 0.908) under controlled laboratory conditions. The body weight, body length, and survival rate in EC4 inbred line of all generations were less than the control population. Inbreeding affected the antibacterial activity, phenoloxidase (PO) activity, and superoxide dismutase (SOD) which decreased at the eleventh generation of EC4 inbred line. This study demonstrated that inbreeding had a negative effect on the economic traits and immune response, but our inbred line was established successfully until F 11 and confirmed by genetic detection using SNP and EST-SSR loci.Entities:
Year: 2020 PMID: 31998771 PMCID: PMC6964724 DOI: 10.1155/2020/5735968
Source DB: PubMed Journal: Int J Genomics ISSN: 2314-436X Impact factor: 2.326
Figure 1The inbred line establishment process for E. carinicauda.
Eight polymorphic EST-SSR markers and estimated polymorphisms.
| Loci | Repeat motif |
|
|
| PIC | GenBank ID | |
|---|---|---|---|---|---|---|---|
| EC002 | GCCATAACAAGTTCCAACCTAA | (GA)12 | 11 | 0.933 | 0.871 | 0.843 | MG976898 |
| ACCAGACTGCTCTCCCACATA | |||||||
|
| |||||||
| EC034 | ACTTCATCCACAAGCAGAGGT | (ATC)7 | 7 | 0.517 | 0.724 | 0.720 | KX394706 |
| GAAGAAGAGGAAGGTGGGGC | |||||||
|
| |||||||
| EC096 | GCAATTTGCCTGTTCGGTCT | (TTG)6 | 6 | 0.367 | 0.597 | 0.664 | KX394741 |
| GGTAGGGGTAAGGGGGTGAT | |||||||
|
| |||||||
| EC205 | CTACCAAAGAGCAAATGGAGTC | (CT)30 | 10 | 0.967 | 0.871 | 0.840 | MG976900 |
| TGAAGTGCTTGGAGTAAAAGATT | |||||||
|
| |||||||
| EC208 | GGACGCTTGTTACAACCTCGAT | (CTT)12 | 8 | 0.667 | 0.840 | 0.802 | MG976894 |
| TTCAGCCTTAGCCATCAGTAAGA | |||||||
|
| |||||||
| EC212 | CGTAGTAGTAATAAAGCGACCCA | (AC)14 | 7 | 0.586 | 0.759 | 0.709 | MG976897 |
| TCGGGCTTGTCTTACTTACCT | |||||||
|
| |||||||
| EC216 | ATCATGAGGAGGACATTGCGT | (GGA)14 | 7 | 0.575 | 0.798 | 0.758 | MG976893 |
| GACTTGACCCTGTTCCTGCC | |||||||
|
| |||||||
| EC219 | GTTTGTCCAAACTCCGAGTGAAA | (CTT)23 | 8 | 0.767 | 0.845 | 0.804 | MG976895 |
| CATCGCAACACCGACAGACA | |||||||
Characteristics of the 31 SNP markers for E. carinicauda.
| SNP loci | SNP type |
|
| PIC | MAF | Annotation |
|---|---|---|---|---|---|---|
| EcSNP011 | A/C | 0.484 | 0.651 | 0.364 | 0.395 | MAP kinase-interacting serine/threonine-protein |
| EcSNP017 | C/T | 0.493 | 0.558 | 0.368 | 0.419 | Actin cytoskeleton organization and biogenesis protein |
| EcSNP020 | A/C | 0.507 | 0.833 | 0.368 | 0.417 | Rhophilin Rho GTPase-binding protein 1 |
| EcSNP037 | A/G | 0.436 | 0.442 | 0.338 | 0.314 | Ras-like GTP-binding protein Rho1 |
| EcSNP056 | C/T | 0.488 | 0.767 | 0.366 | 0.407 | Inositol hexakisphosphate kinase |
| EcSNP057 | G/T | 0.444 | 0.512 | 0.343 | 0.326 | Inositol hexakisphosphate kinase |
| EcSNP063 | A/G | 0.488 | 0.674 | 0.366 | 0.407 | Unknown |
| EcSNP072 | A/G | 0.208 | 0.186 | 0.184 | 0.116 | Heat shock protein 70 |
| EcSNP092 | A/C | 0.361 | 0.326 | 0.293 | 0.233 | Skeletal receptor tyrosine protein kinase |
| EcSNP098 | C/T | 0.460 | 0.419 | 0.351 | 0.349 | Skeletal receptor tyrosine protein kinase |
| EcSNP105 | A/G | 0.503 | 0.791 | 0.374 | 0.465 | Unknown |
| EcSNP131 | C/T | 0.510 | 0.792 | 0.375 | 0.479 | Unknown |
| EcSNP137 | C/T | 0.391 | 0.500 | 0.305 | 0.250 | Condensin complex subunit 2 |
| EcSNP155 | A/G | 0.427 | 0.372 | 0.333 | 0.302 | Heat shock protein 70 |
| EcSNP161 | A/G | 0.506 | 0.674 | 0.375 | 0.500 | Heat shock protein 70 |
| EcSNP177 | C/T | 0.488 | 0.674 | 0.366 | 0.407 | Unknown |
| EcSNP182 | C/T | 0.502 | 0.581 | 0.373 | 0.454 | Heat shock protein 70 |
| EcCat-2 | A/G | 0.497 | 0.833 | 0.368 | 0.417 | Cathepsin L |
| EcFABP-2 | C/T | 0.507 | 0.833 | 0.373 | 0.458 | Fatty acid-binding protein |
| EcMHC-4 | C/T | 0.489 | 0.625 | 0.364 | 0.396 | Myosin heavy chain type 2 |
| EcMHC-5 | A/G | 0.497 | 0.833 | 0.368 | 0.417 | Myosin heavy chain type 2 |
| EcMHC-6 | C/G | 0.507 | 0.583 | 0.373 | 0.458 | Myosin heavy chain type 2 |
| EcMHC-7 | A/G | 0.503 | 0.458 | 0.371 | 0.438 | Myosin heavy chain type 2 |
| EcMLC-2 | C/T | 0.479 | 0.750 | 0.359 | 0.375 | Myosin light chain |
| EcMLC-4 | C/T | 0.497 | 0.583 | 0.368 | 0.417 | Myosin light chain |
| EcTroC-4 | C/T | 0.403 | 0.542 | 0.317 | 0.271 | Troponin C |
| EcSmad3-3 | A/G | 0.511 | 0.833 | 0.375 | 0.500 | Smad3 |
| EcTGFI-6 | G/T | 0.467 | 0.625 | 0.353 | 0.354 | TGF-beta-induced protein |
| EcTGFI-10 | C/T | 0.479 | 0.667 | 0.359 | 0.375 | TGF-beta-induced protein |
| EcTGFI-15 | C/T | 0.489 | 0.792 | 0.364 | 0.396 | TGF-beta-induced protein |
| EcBMP2-3 | C/T | 0.454 | 0.667 | 0.346 | 0.333 | Bone morphogenetic protein 2 |
| Max | 0.511 | 0.833 | 0.375 | 0.500 | ||
| Min | 0.208 | 0.186 | 0.184 | 0.116 | ||
| Mean | 0.467 | 0.625 | 0.352 | 0.382 |
Note: Ho: observed heterozygosity; He: expected heterozygosity; PIC: polymorphism information content; MAF: minor allele frequency.
Genetic characteristics of control population and EC4 inbred line with SNP markers in E. carinicauda.
| Group |
|
|
| PIC |
|---|---|---|---|---|
| Control population | 2.000a | 0.625a | 0.467a | 0.352a |
|
| 1.839ab | 0.318b | 0.288b | 0.218b |
|
| 1.742b | 0.290b | 0.242b | 0.191b |
|
| 1.677b | 0.293b | 0.243b | 0.189b |
|
| 1.742b | 0.301b | 0.255b | 0.199b |
|
| 1.710b | 0.253b | 0.211b | 0.175b |
Note: N: the number of alleles.
Genetic characteristics of control population and EC4 inbred line with EST-SSR markers in E. carinicauda.
| Group |
|
|
| PIC |
|---|---|---|---|---|
| Control population | 6.435a | 0.545a | 0.652a | 0.667a |
|
| 2.239b | 0.252b | 0.304b | 0.254b |
|
| 2.130b | 0.250b | 0.269b | 0.232bc |
|
| 2.217b | 0.252b | 0.275b | 0.204bc |
|
| 2.174b | 0.243b | 0.253b | 0.180c |
|
| 2.087b | 0.229b | 0.236b | 0.174c |
Comparative analysis of growth-related traits between EC4 inbred line and control population.
| Trait | Group | Growth stages | |||
|---|---|---|---|---|---|
| 60 days | 80 days | 100 days | 120 days | ||
| Body weight (g) | Control population | 0.60 ± 0.27a | 1.03 ± 0.32a | 1.44 ± 0.51a | 1.73 ± 0.57a |
|
| 0.53 ± 0.23b | 0.89 ± 0.26b | 1.22 ± 0.41b | 1.51 ± 0.43ab | |
|
| 0.44 ± 0.16bc | 0.85 ± 0.30bc | 1.20 ± 0.38b | 1.46 ± 0.41bc | |
|
| 0.46 ± 0.15bc | 0.74 ± 0.18c | 1.12 ± 0.31b | 1.46 ± 0.21bc | |
|
| 0.40 ± 0.11c | 0.72 ± 0.18c | 0.93 ± 0.21c | 1.32 ± 0.25c | |
|
| 0.41 ± 0.13c | 0.70 ± 0.22c | 0.96 ± 0.17c | 1.36 ± 0.22c | |
|
| |||||
| Body length (mm) | Control population | 33.70 ± 4.58a | 40.69 ± 4.43a | 45.05 ± 5.84a | 48.74 ± 5.83a |
|
| 32.87 ± 4.72ab | 39.47 ± 3.31ab | 43.57 ± 4.87ab | 47.19 ± 4.98ab | |
|
| 30.65 ± 4.21c | 38.46 ± 3.82bc | 43.60 ± 4.80ab | 46.01 ± 4.71ab | |
|
| 31.01 ± 3.79bc | 36.49 ± 3.11c | 41.40 ± 3.85bc | 45.42 ± 2.25b | |
|
| 29.58 ± 2.62c | 35.88 ± 3.08c | 39.72 ± 3.23c | 44.96 ± 2.92b | |
|
| 29.60 ± 2.72c | 35.91 ± 3.15d | 40.33 ± 2.48c | 44.43 ± 2.63b | |
|
| |||||
| Survival rate (%) | Control population | 95.00 ± 1.73a | 82.00 ± 2.00a | 68.00 ± 2.83a | 55.00 ± 3.32a |
|
| 90.00 ± 3.54ab | 73.75 ± 2.17ab | 62.50 ± 2.50ab | 48.75 ± 2.17ab | |
|
| 88.75 ± 5.45ab | 74.55 ± 9.07ab | 66.25 ± 3.78ab | 52.39 ± 6.86ab | |
|
| 86.67 ± 2.36b | 72.22 ± 1.96b | 59.72 ± 1.96b | 47.22 ± 1.96ab | |
|
| 90.00 ± 2.00ab | 73.00 ± 1.73ab | 60.00 ± 4.00b | 44.00 ± 2.83b | |
|
| 86.00 ± 3.74b | 70.00 ± 3.16b | 59.00 ± 3.16b | 42.00 ± 3.74b | |
Inbreeding depression on growth-related traits of five levels of inbreeding in EC4 inbred line at 120-day stage.
| Group | IDC (body weight) | IDC (body length) | IDC (survival rate) |
|---|---|---|---|
|
| -16.20% | -4.19% | -14.59% |
|
| -19.13% | -6.79% | -6.02% |
|
| -18.17% | -7.89% | -16.51% |
|
| -26.75% | -8.81% | -22.57% |
|
| -23.55% | -9.72% | -26.03% |
Note: IDC: the inbreeding depression coefficient.
The immune parameters and antioxidant status of control population and different inbreeding generations in E. carinicauda.
| Generation | Total haemocyte count | Antibacterial activity | HEM concentration | AKP activity | LZM activity | PO activity | SOD activity | CAT activity |
|---|---|---|---|---|---|---|---|---|
| (×107/ml) | (U) | (mg/ml) | (U/ml) | (U/ml) | (U) | (U) | (U/ml) | |
| Control population | 5.86 ± 0.14a | 0.48 ± 0.02a | 6.36 ± 0.09a | 6.66 ± 0.17a | 0.40 ± 0.01a | 0.40 ± 0.02a | 6.92 ± 0.17a | 16.40 ± 0.41a |
|
| 5.89 ± 0.12a | 0.48 ± 0.03a | 6.37 ± 0.16a | 6.71 ± 0.18a | 0.40 ± 0.03a | 0.41 ± 0.02a | 6.69 ± 0.23a | 15.33 ± 0.58a |
|
| 5.72 ± 0.16a | 0.47 ± 0.02a | 6.49 ± 0.34a | 6.64 ± 0.21a | 0.37 ± 0.03a | 0.40 ± 0.02a | 6.95 ± 0.31a | 15.89 ± 1.01a |
|
| 5.43 ± 0.37a | 0.46 ± 0.02a | 6.21 ± 0.23a | 6.68 ± 0.20a | 0.39 ± 0.01a | 0.38 ± 0.01a | 6.74 ± 0.26a | 15.77 ± 0.52a |
|
| 5.52 ± 0.23a | 0.47 ± 0.01a | 5.87 ± 0.27a | 6.15 ± 0.16b | 0.39 ± 0.02a | 0.34 ± 0.01b | 6.52 ± 0.18a | 12.96 ± 0.85b |
|
| 5.63 ± 0.20a | 0.40 ± 0.01b | 6.07 ± 0.17a | 6.52 ± 0.25a | 0.38 ± 0.02a | 0.30 ± 0.01c | 6.01 ± 0.25b | 14.70 ± 0.91a |
Note: HEM: haemocyanin; AKP: alkaline phosphatase; LZM: lysozyme; PO: phenoloxidase; SOD: superoxide dismutase; CAT: catalase.